Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

352.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 445.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 106.14m
  • Volume: 200,824
  • Market Cap: £373.60m
  • RiskGrade: 125
  • Beta: 0.00

Latest ShareCast News

Oxford Biomedica acquires last 10pc stake in US subsidiary

By Josh White

Date: Monday 23 Jun 2025

(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.

Oxford Biomedica reports first-half revenue growth

By Josh White

Date: Monday 23 Sep 2024

(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.

Oxford Biomedica still expecting small loss after solid first half

By Josh White

Date: Thursday 08 Aug 2024

(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation Oxford Biomedica reported a strong first-half trading performance in an update on Thursday, with revenue expected to reach £50m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 352.00p
Change Today -1.00p
% Change -0.28 %
52 Week High 445.00p
52 Week Low 232.50p
Volume 200,824
Shares Issued 106.14m
Market Cap £373.60m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.62% below the market average31.62% below the market average31.62% below the market average31.62% below the market average31.62% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Price Trend
32.31% below the market average32.31% below the market average32.31% below the market average32.31% below the market average32.31% below the market average
17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average
Income Not Available
Growth
2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
15:20 141 @ 354.00p
16:35 36,237 @ 352.00p
16:35 95 @ 352.00p
16:35 191 @ 352.00p
16:35 303 @ 352.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page